Carl A. Spalding
Directeur/Membre du Conseil chez inVentiv Health Clinical, Inc.
Profil
Carl A.
Spalding is currently a Director at inVentiv Health Clinical, Inc. He previously held positions as Chairman at LAB Research, Inc., Director at EMD Millipore Corp., Director at Atterx Biotherapeutics, Inc., Director at Millipore Bioscience Caribe Ltd., Director at Prologue Research International, Inc., Vice President & GM-Ross Products Division at Abbott Laboratories, Executive Vice President at Cardinal Health, Inc., Principal at Johnson & Johnson, and President & Chief Operating Officer at PAREXEL International Corp.
Postes actifs de Carl A. Spalding
| Sociétés | Poste | Début |
|---|---|---|
inVentiv Health Clinical, Inc.
 inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health Clinical, Inc. provides clinical research and drug development services. It provides its services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The firm offers clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. The company was founded in 1984 and is headquartered in Princeton, NJ. | Directeur/Membre du Conseil | 22/03/2010 |
Anciens postes connus de Carl A. Spalding
| Sociétés | Poste | Fin |
|---|---|---|
| PAREXEL INTERNATIONAL CORPORATION | President | 30/06/2005 |
Prologue Research International, Inc.
 Prologue Research International, Inc. Miscellaneous Commercial ServicesCommercial Services Prologue Research, Inc., is a leading global oncology contract research organization (CRO) founded in 1998. The Company offers a full range of clinical research services for Phase I-IV international or US-based clinical trials in oncology and oncology-related studies. Prologue provides its clients with world-class experience in running oncology trials, a deeply-qualified staff, access to an extensive investigator database, and state-of-the-art computerized systems uniquely designed for complicated cancer trials. They offer experience and talent that enable more efficient product development while maintaining unparalleled quality. It is their dedication to detail and expertise in the oncology field that set them apart from other CROs. They take great pride in being a niche contract research organization dedicated to one therapeutic field: oncology. This streamlined focus allows them to provide a level of attention to detail that others can only promise. They have never had a trial pulled due to client dissatisfaction. And they are proud of their reputation as the go-to CRO for ''rescue'' studies. | Directeur/Membre du Conseil | - |
| Millipore Bioscience Caribe Ltd. | Directeur/Membre du Conseil | - |
LAB Research, Inc.
 LAB Research, Inc. Miscellaneous Commercial ServicesCommercial Services LAB Research, Inc. provides in-vivo non-clinical research services for the global pharmaceutical, biotechnology, agrochemical and petro-chemical industries. The company performs pre-clinical studies required for the development of drugs used in the treatment of human conditions or diseases. It offers pre-Phase I, pre-Phase II/III and other services. The company's pre-Phase I services include general toxicology, genotoxicity, safety pharmacology, bioanalytics and efficacy studies. Its pre-Phase II/III services include reproductive toxicology, carcinogenicity and absorption, distribution, metabolism and excretion studies. The company was founded in 1998 and is headquartered in Laval, Canada. | Président | - |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| CARDINAL HEALTH, INC. | Distribution Services |
| ABBOTT LABORATORIES | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| Entreprise privées | 7 |
|---|---|
PAREXEL International Corp.
 PAREXEL International Corp. Miscellaneous Commercial ServicesCommercial Services PAREXEL International Corp. provides biopharmaceutical services. It offers clinical research and logistics, medical communications, consulting, commercialization and advanced technology products and services for pharmaceutical, biotechnology and medical device industries. The company was founded in 1983 and is headquartered in Newton, MA. | Commercial Services |
Atterx Biotherapeutics, Inc.
 Atterx Biotherapeutics, Inc. Pharmaceuticals: OtherHealth Technology Atterx Biotherapeutics, Inc. develops novel antibacterial technologies. It developed two products to fight multi-drug resistant, Gram negative bacteria. The first product, C-1205 utilizes bacterial interference technology to prevent catheter associated urinary tract infections and GN-4474 has been developed using this technology to target Gram negative bacteria. It has been shown to be effective in animal infection models and an IND filing is expected in 2015. The company was founded by Richard R. Burgess and Marcin Filutowicz in 2001 and is headquartered in Madison, WI. | Health Technology |
EMD Millipore Corp.
 EMD Millipore Corp. Miscellaneous Commercial ServicesCommercial Services EMD Millipore Corp. engages in the provision of laboratory materials, technologies, and services to the life science industry. The company was founded by Jack Bush in 1954 and is headquartered in Burlington, MA. | Commercial Services |
LAB Research, Inc.
LAB Research, Inc. Miscellaneous Commercial ServicesCommercial Services LAB Research, Inc. provides in-vivo non-clinical research services for the global pharmaceutical, biotechnology, agrochemical and petro-chemical industries. The company performs pre-clinical studies required for the development of drugs used in the treatment of human conditions or diseases. It offers pre-Phase I, pre-Phase II/III and other services. The company's pre-Phase I services include general toxicology, genotoxicity, safety pharmacology, bioanalytics and efficacy studies. Its pre-Phase II/III services include reproductive toxicology, carcinogenicity and absorption, distribution, metabolism and excretion studies. The company was founded in 1998 and is headquartered in Laval, Canada. | Commercial Services |
inVentiv Health Clinical, Inc.
inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health Clinical, Inc. provides clinical research and drug development services. It provides its services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The firm offers clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. The company was founded in 1984 and is headquartered in Princeton, NJ. | Commercial Services |
| Millipore Bioscience Caribe Ltd. | |
Prologue Research International, Inc.
Prologue Research International, Inc. Miscellaneous Commercial ServicesCommercial Services Prologue Research, Inc., is a leading global oncology contract research organization (CRO) founded in 1998. The Company offers a full range of clinical research services for Phase I-IV international or US-based clinical trials in oncology and oncology-related studies. Prologue provides its clients with world-class experience in running oncology trials, a deeply-qualified staff, access to an extensive investigator database, and state-of-the-art computerized systems uniquely designed for complicated cancer trials. They offer experience and talent that enable more efficient product development while maintaining unparalleled quality. It is their dedication to detail and expertise in the oncology field that set them apart from other CROs. They take great pride in being a niche contract research organization dedicated to one therapeutic field: oncology. This streamlined focus allows them to provide a level of attention to detail that others can only promise. They have never had a trial pulled due to client dissatisfaction. And they are proud of their reputation as the go-to CRO for ''rescue'' studies. | Commercial Services |
